Company intelligence / Profile preview

242 Cannabis

Gainesville, Florida, United States

Ownership: Private
Employees: ~150
Development stage: Other

Overview

242 Cannabis was a medical cannabis cultivation and processing company that operated a significant production facility in Gainesville, Florida. The company owned a 387-acre property featuring 200,000 square feet of greenhouse space and advanced processing labs designed for large-scale medical marijuana production. In 2018, it was acquired by Liberty Health Sciences to serve as their primary Florida production hub, subsequently becoming known as the Liberty 360 Innovation Campus. Following the acquisition of Liberty Health Sciences by Ayr Wellness in 2021, the facility continues to function as a core component of Ayr's manufacturing and cultivation infrastructure in the state.

Therapeutic areas: PsychiatryNeurologyGastroenterology
Modalities: Small moleculePlant-derived cannabinoids
Industry: Biotech

Beyond the preview

Go deeper on 242 Cannabis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 242 Cannabis.

Explore the full profile